Precipio Inc (PRPO)

$20.78 -0.07 (-0.34%)
Market Cap 33.66M
Revenue (ttm) 18.53M
Net Income (ttm) -4.29M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -23.15%
Debt to Equity Ratio 0.01
Volume 9,100
Avg Vol 14,516
Day's Range N/A - N/A
Shares Out 1.62M
Stochastic %K 91%
Beta 1.18
Analysts Strong Buy
Price Target $40.00

Company Profile

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Hav...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 203 787 7888
Address:
4 Science Park, 3rd Floor, New Haven, United States
Awaywithshorts
Awaywithshorts Oct. 3 at 8:12 PM
$PRPO 30 Next week.
0 · Reply
Newbie3611
Newbie3611 Oct. 3 at 6:32 PM
$PRPO Will today be the last day we see sub-$1 per share? I certainly hope so. Only about 300 shares traded today under $1. It has taken FOREVER to get here. It has been almost 1 month since the last mini-pop so we should be due up for another one next week. I only need to get to just under $5 per share to break even. Can we do it???
0 · Reply
SinnagodKosher
SinnagodKosher Oct. 2 at 2:44 PM
$PRPO next stop, 40.
0 · Reply
Loren77
Loren77 Oct. 2 at 2:09 PM
$PRPO There's nothing more beautiful than an uptrend without volume
0 · Reply
houtx1
houtx1 Oct. 2 at 12:44 PM
$PRPO posted this on 9/23
0 · Reply
Loren77
Loren77 Oct. 2 at 12:28 PM
$PRPO The RSI is heating up. We could make a new high, and use around $20 as new support. It's a good plan.
0 · Reply
Rowdyreptile
Rowdyreptile Oct. 2 at 12:05 PM
$PRPO 🚨 🚨 @houtx1 is bullish here again!! 🚨BUY SIGNAL 🚨
0 · Reply
Awaywithshorts
Awaywithshorts Oct. 2 at 9:29 AM
$PRPO Incoming boom
0 · Reply
houtx1
houtx1 Oct. 2 at 2:00 AM
$PRPO Warrants! I am sure the warrant holder has more to unload but maybe he is waiting to sell at a higher price. He may have recovered close to his $1 million investment. The rest of the sales are his profit for taking the risk. My guess!!
0 · Reply
houtx1
houtx1 Oct. 2 at 1:57 AM
$PRPO Chart! Bullish breakout of the range. Notice larger daily candle with higher volume compared to the last 5 or 6 trading days. I havent checked the bid ask spread, if its large, expect wide swings. A narrow range is best, shows more liquidity. Traders prefer it so they can get in and out quick if necessary. Lets see if prior resistance becomes new support. JMO
0 · Reply
Latest News on PRPO
Precipio, Inc. (PRPO) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 9:03 PM EDT - 7 weeks ago

Precipio, Inc. (PRPO) Q2 2025 Earnings Call Transcript

Precipio Announces its Q2-2025 Financial Results

Aug 13, 2025, 5:00 PM EDT - 7 weeks ago

Precipio Announces its Q2-2025 Financial Results

Precipio Announces Q2-2025 Shareholder Update Call

Jul 31, 2025, 4:30 PM EDT - 2 months ago

Precipio Announces Q2-2025 Shareholder Update Call

Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless

Jul 11, 2025, 4:30 PM EDT - 3 months ago

Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless

Precipio, Inc. (PRPO) Q1 2025 Earnings Call Transcript

May 15, 2025, 6:02 PM EDT - 5 months ago

Precipio, Inc. (PRPO) Q1 2025 Earnings Call Transcript

Precipio Announces its Q1-2025 Financial Results

May 14, 2025, 5:00 PM EDT - 5 months ago

Precipio Announces its Q1-2025 Financial Results

Precipio Announces Q1-2025 Shareholder Update Call

May 1, 2025, 5:00 PM EDT - 5 months ago

Precipio Announces Q1-2025 Shareholder Update Call

Precipio, Inc. (PRPO) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 10:50 PM EDT - 6 months ago

Precipio, Inc. (PRPO) Q4 2024 Earnings Call Transcript

Precipio Announces Q4 and year-end 2024 Shareholder Update Call

Mar 17, 2025, 5:00 PM EDT - 7 months ago

Precipio Announces Q4 and year-end 2024 Shareholder Update Call

Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited)

Feb 25, 2025, 9:30 AM EST - 7 months ago

Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited)

Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs

Jan 16, 2025, 5:00 PM EST - 9 months ago

Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs

Precipio, Inc. (PRPO) Q3 2024 Earnings Call Transcript

Nov 18, 2024, 6:16 PM EST - 11 months ago

Precipio, Inc. (PRPO) Q3 2024 Earnings Call Transcript

Precipio Announces Q3-2024 Shareholder Update Call

Nov 6, 2024, 5:00 PM EST - 11 months ago

Precipio Announces Q3-2024 Shareholder Update Call

Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation Subtyping

Oct 8, 2024, 10:00 AM EDT - 1 year ago

Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation Subtyping

Precipio Announces Employee Stock Option Plan Repricing

Sep 6, 2024, 4:00 PM EDT - 1 year ago

Precipio Announces Employee Stock Option Plan Repricing

Precipio, Inc. (PRPO) Q2 2024 Earnings Call Transcript

Aug 19, 2024, 5:55 PM EDT - 1 year ago

Precipio, Inc. (PRPO) Q2 2024 Earnings Call Transcript

Precipio Announces Q2-2024 Shareholder Update Call

Aug 15, 2024, 5:00 PM EDT - 1 year ago

Precipio Announces Q2-2024 Shareholder Update Call

Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven

Jul 25, 2024, 9:00 AM EDT - 1 year ago

Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven

Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024

Jul 17, 2024, 9:00 AM EDT - 1 year ago

Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024

Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders

Jun 13, 2024, 4:00 PM EDT - 1 year ago

Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

Jun 12, 2024, 4:00 PM EDT - 1 year ago

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

Precipio Secures a short-term $500K Credit Facility

May 6, 2024, 5:00 PM EDT - 1 year ago

Precipio Secures a short-term $500K Credit Facility

Precipio Announces Year end 2023 Shareholder Update Call

Mar 25, 2024, 5:00 PM EDT - 1 year ago

Precipio Announces Year end 2023 Shareholder Update Call

Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY

Feb 13, 2024, 10:00 AM EST - 1 year ago

Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY

Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer

Feb 6, 2024, 10:00 AM EST - 1 year ago

Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer

Precipio's Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter

Jan 23, 2024, 10:00 AM EST - 1 year ago

Precipio's Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter

Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan

Jan 17, 2024, 10:30 AM EST - 1 year ago

Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan

Precipio Announces Christina Valauri joins the Board of Directors

Jan 2, 2024, 9:00 AM EST - 1 year ago

Precipio Announces Christina Valauri joins the Board of Directors

Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024

Dec 14, 2023, 4:30 PM EST - 1 year ago

Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024

Precipio, Inc. (PRPO) Q3 2023 Earnings Call Transcript

Nov 20, 2023, 6:38 PM EST - 2 years ago

Precipio, Inc. (PRPO) Q3 2023 Earnings Call Transcript

Precipio Announces Q3-2023 Shareholder Update Call

Nov 16, 2023, 5:00 PM EST - 2 years ago

Precipio Announces Q3-2023 Shareholder Update Call

Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022

Oct 18, 2023, 9:00 AM EDT - 2 years ago

Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022

Precipio's Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023

Oct 3, 2023, 10:00 AM EDT - 2 years ago

Precipio's Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023

Precipio Continues to Sign New HemeScreen™ Customers

Sep 28, 2023, 9:00 AM EDT - 2 years ago

Precipio Continues to Sign New HemeScreen™ Customers

Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven

Sep 25, 2023, 11:00 AM EDT - 2 years ago

Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven

Precipio Takes Final Step Towards Regaining Nasdaq Compliance

Sep 21, 2023, 9:00 AM EDT - 2 years ago

Precipio Takes Final Step Towards Regaining Nasdaq Compliance

Precipio's Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan

Sep 13, 2023, 9:30 AM EDT - 2 years ago

Precipio's Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan

Precipio, Inc. (PRPO) Q2 2023 Earnings Call Transcript

Aug 17, 2023, 6:32 PM EDT - 2 years ago

Precipio, Inc. (PRPO) Q2 2023 Earnings Call Transcript

Precipio Announces Q2-2023 Shareholder Update Call

Aug 10, 2023, 5:00 PM EDT - 2 years ago

Precipio Announces Q2-2023 Shareholder Update Call

Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel

Aug 8, 2023, 9:00 AM EDT - 2 years ago

Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel

Precipio's Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakeven

Aug 3, 2023, 9:00 AM EDT - 2 years ago

Precipio's Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakeven

Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023

Aug 1, 2023, 9:00 AM EDT - 2 years ago

Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023

Precipio's Omnia™ Methodology Enables Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow Biopsy

Jun 14, 2023, 9:49 AM EDT - 2 years ago

Precipio's Omnia™ Methodology Enables Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow Biopsy

Precipio Enters into Collaboration with Prestigious New York-based Institution to Develop Revolutionary Brain Tumor Panel using HemeScreen® Technology

Jun 13, 2023, 9:00 AM EDT - 2 years ago

Precipio Enters into Collaboration with Prestigious New York-based Institution to Develop Revolutionary Brain Tumor Panel using HemeScreen® Technology

Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

Jun 8, 2023, 8:30 AM EDT - 2 years ago

Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

Projected cash burn reduced by $1.5 million annually from Three Operational Efficiency Projects

Jun 7, 2023, 9:30 AM EDT - 2 years ago

Projected cash burn reduced by $1.5 million annually from Three Operational Efficiency Projects

Precipio's Lab Detects BCR-ABL1 Oncogene Co-Expression of p190 & p210 Isoforms in a CML Patient By Using HemeScreen® Technology

May 22, 2023, 11:00 AM EDT - 2 years ago

Precipio's Lab Detects BCR-ABL1 Oncogene Co-Expression of p190 & p210 Isoforms in a CML Patient By Using HemeScreen® Technology

Precipio, Inc. (PRPO) Q1 2023 Earnings Call Transcript

May 18, 2023, 12:34 PM EDT - 2 years ago

Precipio, Inc. (PRPO) Q1 2023 Earnings Call Transcript

Precipio Shares Growth Catalysts For HemeScreen

May 17, 2023, 4:00 PM EDT - 2 years ago

Precipio Shares Growth Catalysts For HemeScreen

Precipio Announces Q1-2023 Shareholder Update Call

May 15, 2023, 4:00 PM EDT - 2 years ago

Precipio Announces Q1-2023 Shareholder Update Call

Awaywithshorts
Awaywithshorts Oct. 3 at 8:12 PM
$PRPO 30 Next week.
0 · Reply
Newbie3611
Newbie3611 Oct. 3 at 6:32 PM
$PRPO Will today be the last day we see sub-$1 per share? I certainly hope so. Only about 300 shares traded today under $1. It has taken FOREVER to get here. It has been almost 1 month since the last mini-pop so we should be due up for another one next week. I only need to get to just under $5 per share to break even. Can we do it???
0 · Reply
SinnagodKosher
SinnagodKosher Oct. 2 at 2:44 PM
$PRPO next stop, 40.
0 · Reply
Loren77
Loren77 Oct. 2 at 2:09 PM
$PRPO There's nothing more beautiful than an uptrend without volume
0 · Reply
houtx1
houtx1 Oct. 2 at 12:44 PM
$PRPO posted this on 9/23
0 · Reply
Loren77
Loren77 Oct. 2 at 12:28 PM
$PRPO The RSI is heating up. We could make a new high, and use around $20 as new support. It's a good plan.
0 · Reply
Rowdyreptile
Rowdyreptile Oct. 2 at 12:05 PM
$PRPO 🚨 🚨 @houtx1 is bullish here again!! 🚨BUY SIGNAL 🚨
0 · Reply
Awaywithshorts
Awaywithshorts Oct. 2 at 9:29 AM
$PRPO Incoming boom
0 · Reply
houtx1
houtx1 Oct. 2 at 2:00 AM
$PRPO Warrants! I am sure the warrant holder has more to unload but maybe he is waiting to sell at a higher price. He may have recovered close to his $1 million investment. The rest of the sales are his profit for taking the risk. My guess!!
0 · Reply
houtx1
houtx1 Oct. 2 at 1:57 AM
$PRPO Chart! Bullish breakout of the range. Notice larger daily candle with higher volume compared to the last 5 or 6 trading days. I havent checked the bid ask spread, if its large, expect wide swings. A narrow range is best, shows more liquidity. Traders prefer it so they can get in and out quick if necessary. Lets see if prior resistance becomes new support. JMO
0 · Reply
Awaywithshorts
Awaywithshorts Oct. 1 at 8:31 PM
$PRPO Catches attention and it’s gone !!
0 · Reply
Loren77
Loren77 Oct. 1 at 6:05 PM
$PRPO Now I think the accumulation phase isn't over yet. The only difference is that the range below $10 was completely exhausted. If that's the case, the starting point for the bullish momentum, with decent volume, will be at least above $20, perhaps above $30.
0 · Reply
Loren77
Loren77 Oct. 1 at 6:00 PM
$PRPO status: zero Fomo 😇
0 · Reply
Messi0321
Messi0321 Oct. 1 at 5:58 PM
$PRPO we about to test the highs of 22$. Pass dat, 33$ is next resis
0 · Reply
Messi0321
Messi0321 Sep. 30 at 6:59 PM
$PRPO dat warrant was selling it 5k-10k volume a day. Now lets go up.
0 · Reply
SinnagodKosher
SinnagodKosher Sep. 30 at 6:58 PM
$PRPO UPPPP 😤🤜🏼
0 · Reply
eddiel
eddiel Sep. 30 at 3:44 PM
$PRPO someone slap that ask
0 · Reply
Awaywithshorts
Awaywithshorts Sep. 30 at 12:15 AM
$PRPO Confident and see a potential for buy out offers.
0 · Reply
Travelling
Travelling Sep. 29 at 2:36 PM
$FLGC buying some to hold, also $SLE $PRPO watching $SNDL $TLRY
0 · Reply
Awaywithshorts
Awaywithshorts Sep. 29 at 12:34 PM
$PRPO Huge manipulation scare tactic. So Ethingbhuge must be coming for pressure Like this
0 · Reply
Awaywithshorts
Awaywithshorts Sep. 27 at 11:08 AM
$PRPO Prime candidate for a buy out 😉
0 · Reply
Millionaireb437
Millionaireb437 Sep. 26 at 9:17 PM
$BIAF $LLY $MRK $PFE $PRPO
0 · Reply